March 17, 2020 / 2:22 PM / in 17 days

CureVac says no requests to reserve production for U.S., scientists were not lured

FRANKFURT, March 17 (Reuters) - German vaccine developer CureVac has not received a takeover offer from the United States, was not asked to reserve production slots nor were its scientists lured to move to the U.S., the firm’s acting Chief Executive Franz-Werner Haas said in a media call on Tuesday. (Reporting by Ludwig Burger Editing by Michelle Martin)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below